Sleep and Circadian Rhythm Disruption in Social Jetlag and Mental Illness - Progress in Molecular Biology and Translational Science - page 344

46. Tunbridge EM, Weinberger DR, Harrison PJ. A novel protein isoform of catechol
O-methyltransferase (COMT): brain expression analysis in schizophrenia and bipolar
disorder and effect of Val158Met genotype. Mol Psychiatry . 2006;11(2):116-117.
47. Williams NM, O'Donovan MC, Owen MJ. Is the dysbindin gene (DTNBP1) a suscep-
tibility gene for schizophrenia? Schizophr Bull . 2005;31(4):800-805.
48. Corradini I, Verderio C, Sala M, Wilson MC, Matteoli M. SNAP-25 in neuropsychi-
atric disorders. Ann N Y Acad Sci . 2009;1152:93-99.
49. Vacic V, McCarthy S, Malhotra D, et al. Duplications of the neuropeptide receptor gene
VIPR2 confer significant risk for schizophrenia. Nature . 2011;471(7339):499-503.
50. Lipina TV, Wang M, Liu F, Roder JC. Synergistic interactions between PDE4B and
GSK-3: DISC1 mutant mice. Neuropharmacology . 2012;62(3):1252-1262.
51. Fatemi SH, King DP, Reutiman TJ, et al. PDE4B polymorphisms and decreased PDE4B
expression are associated with schizophrenia. Schizophr Res . 2008;101(1-3):36-49.
52. Numata S, Ueno S, Iga J, et al. Positive association of the PDE4B (phosphodiesterase 4B)
gene with schizophrenia in the Japanese population. J Psychiatr Res . 2008;43(1):7-12.
53. Tomppo L, Hennah W, Lahermo P, et al. Association between genes of Disrupted in
schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1
pathway in the etiology of major mental illnesses. Biol Psychiatry . 2009;65(12):1055-1062.
54. Brzozka MM, Radyushkin K, Wichert SP, Ehrenreich H, Rossner MJ. Cognitive and
sensorimotor gating impairments in transgenic mice overexpressing the schizophrenia
susceptibility gene Tcf4 in the brain. Biol Psychiatry . 2010;68(1):33-40.
55. Ripke S, Sanders AR, Kendler KS, et al. Genome-wide association study identifies five
new schizophrenia loci. Nat Genet . 2011;43(10):969-976.
56. O'Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with
schizophrenia by genome-wide association and follow-up. Nat Genet . 2008;40
(9):1053-1055.
57. Oliver PL, Sobczyk MV, Maywood ES, et al. Disrupted circadian rhythms in a mouse
model of schizophrenia. Curr Biol . 2012;22(4):314-319.
58. Hughes AT, Piggins HD. Behavioral responses of Vipr2-/- mice to light. J Biol Rhythms .
2008;23(3):211-219.
59. Johnson MA, Devay P, Role LW. The cystine-rich domain of the neuregulin-1 gene
(crd-NRG-1) is required for survival of a subset of neurons in the suprachiasmatic
nucleus (SCN). Washington, DC: Society for Neuroscience; 2002. Online. 2002

Abstract Viewer/Itinerary Planner, 2002 .
60. Maywood ES, Reddy AB, Wong GK, et al. Synchronization and maintenance of time-
keeping in suprachiasmatic circadian clock cells by neuropeptidergic signaling. Curr Biol .
2006;16(6):599-605.
61. Jeans AF, Oliver PL, Johnson R, et al. A dominant mutation in Snap25 causes impaired
vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc Natl
Acad Sci USA . 2007;104(7):2431-2436.
62. Oliver PL, Davies KE. Interaction between environmental and genetic factors modulates
schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk. Hum Mol
Genet . 2009;18(23):4576-4589.
63. Lin HF, Liu YL, Liu CM, Hung SI, Hwu HG, Chen WJ. Neuregulin 1 gene and var-
iations in perceptual aberration of schizotypal personality in adolescents. Psychol Med .
2005;35(11):1589-1598.
64. Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR.
Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia.
Mol Psychiatry . 2004;9(3):299-307.
65. Snodgrass-Belt P, Gilbert JL, Davis FC. Central administration of transforming growth
factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in ham-
sters. Brain Res . 2005;1038(2):171-182.